Home

Articles from Albert Invent

Albert Invent Partners with Kenvue to Build the Future of Consumer Health Products With the Help of AI
Frontier AI company Albert Invent today announced a strategic partnership with Kenvue Inc. (NYSE: KVUE), maker of consumer health products like Zyrtec®, Neutrogena®, and Listerine®, to accelerate end-to-end R&D efforts across the company’s global portfolio of brands. The partnership enables Kenvue to streamline, digitalize, and accelerate the end-to-end product lifecycle by leveraging Albert Invent's foundational AI models.
By Albert Invent · Via Business Wire · October 14, 2025
Albert Invent, Whose Leading AI-Enabled End-to-End Platform Accelerates Innovation in Chemical and Materials R&D, Launches Subsidiary in Japan
Albert Invent, whose world-leading end-to-end artificial intelligence-driven platform is transforming R&D in the chemical and materials industries, today announced the launch of its Japanese subsidiary, Albert Invent Japan K.K., as part of the company’s continued global expansion. This investment reflects Albert’s deep commitment to supporting innovation in Japan’s world-class chemical and materials industry, which is the fourth largest in the world and has long been recognized for its technical excellence and scientific leadership.
By Albert Invent · Via Business Wire · September 10, 2025
Chemistry AI Platform Albert Invent Announces Growth Investment Led by J.P. Morgan Private Capital
Albert Invent, whose end-to-end R&D platform accelerates chemical innovation in materials science through the application of AI and machine learning, today announced a growth funding round led by J.P. Morgan Private Capital’s Growth Equity Partners, with participation from Coatue and TCV. This latest investment round brings Albert Invent’s total funding to more than $45M. The funds will be used to continue building the team globally, hiring in Germany, Japan, India, and the US. The company will also scale to meet customer demand for Albert Invent as an industry-wide shift toward digitalization continues to drive growth across the globe. Albert Invent is used by the world's leading chemical, material science, and personal care companies including Chemours, Diversey, Henkel, Keystone Industries, Nouryon, and Solenis to unify R&D processes, accelerate innovation through AI, and transform how new products are brought to market.
By Albert Invent · Via Business Wire · February 24, 2025
Leading Materials Science R&D Platform Albert Invent Announces $22.5 Million Series A and Launches Breakthrough™ to Accelerate Chemical Innovation
Albert Invent, whose end-to-end R&D platform accelerates chemical innovation in materials science using AI, today announced a $22.5 million Series A funding round led by Coatue, with participation from TCV, Index Ventures, F-Prime, and Homebrew.
By Albert Invent · Via Business Wire · December 11, 2024